Your browser doesn't support javascript.
loading
T follicular helper phenotype predicts response to histone deacetylase inhibitors in relapsed/refractory peripheral T-cell lymphoma.
Ghione, Paola; Faruque, Promie; Mehta-Shah, Neha; Seshan, Venkatraman; Ozkaya, Neval; Bhaskar, Shakthi; Yeung, James; Spinner, Michael A; Lunning, Matthew; Inghirami, Giorgio; Moskowitz, Alison; Galasso, Natasha; Ganesan, Nivetha; van der Weyden, Carrie; Ruan, Jia; Prince, H Miles; Trotman, Judith; Advani, Ranjana; Dogan, Ahmet; Horwitz, Steven.
Afiliación
  • Ghione P; Lymphoma Service, Department of Medicine, Memorial Sloan Kettering Cancer Center, New York, NY.
  • Faruque P; Lymphoma and Myeloma Service, Department of Medicine, Roswell Park Comprehensive Cancer Center, Buffalo, NY.
  • Mehta-Shah N; Lymphoma Service, Department of Medicine, Memorial Sloan Kettering Cancer Center, New York, NY.
  • Seshan V; Lymphoma Service, Department of Medicine, Memorial Sloan Kettering Cancer Center, New York, NY.
  • Ozkaya N; Department of Hematology and Oncology, Washington University School of Medicine, St. Louis, MO.
  • Bhaskar S; Department of Epidemiology and Biostatistics and.
  • Yeung J; Department of Pathology, Memorial Sloan Kettering Cancer Center, New York, NY.
  • Spinner MA; Department of Hematology and Oncology, Washington University School of Medicine, St. Louis, MO.
  • Lunning M; Hematology Department, Concord Hospital, University of Sydney, Sydney, Australia.
  • Inghirami G; Department of Oncology, Stanford University, Stanford CA.
  • Moskowitz A; Lymphoma Service, Department of Medicine, Memorial Sloan Kettering Cancer Center, New York, NY.
  • Galasso N; Division of Oncology and Hematology, Department of Internal Medicine, University of Nebraska Medical Center, Omaha, NE.
  • Ganesan N; Department of Medicine, Weill Cornell Medicine, New York, NY.
  • van der Weyden C; Lymphoma Service, Department of Medicine, Memorial Sloan Kettering Cancer Center, New York, NY.
  • Ruan J; Lymphoma Service, Department of Medicine, Memorial Sloan Kettering Cancer Center, New York, NY.
  • Prince HM; Lymphoma Service, Department of Medicine, Memorial Sloan Kettering Cancer Center, New York, NY.
  • Trotman J; Division of Cancer Medicine, Peter MacCallum Cancer Center, Parkville, Australia; and.
  • Advani R; Sir Peter MacCallum Department of Oncology, University of Melbourne, Parkville, Australia.
  • Dogan A; Department of Medicine, Weill Cornell Medicine, New York, NY.
  • Horwitz S; Division of Cancer Medicine, Peter MacCallum Cancer Center, Parkville, Australia; and.
Blood Adv ; 4(19): 4640-4647, 2020 10 13.
Article en En | MEDLINE | ID: mdl-33002132
Asunto(s)
Texto completo
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Colección: 01-internacional Banco de datos: MEDLINE Asunto principal: Linfoma de Células T Periférico Tipo de estudio: Observational_studies / Prognostic_studies / Risk_factors_studies Límite: Humans Idioma: En Revista: Blood Adv Año: 2020 Tipo del documento: Article
Texto completo
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Colección: 01-internacional Banco de datos: MEDLINE Asunto principal: Linfoma de Células T Periférico Tipo de estudio: Observational_studies / Prognostic_studies / Risk_factors_studies Límite: Humans Idioma: En Revista: Blood Adv Año: 2020 Tipo del documento: Article